CLINICAL_TRIALS
trial_result
· 2017-12-14
Clinical Trial Update: Alendronate to Prevent Loss of Bronchoprotection in Asthma [Phase 2, Phase 3]
Summary
Clinical trial update for alendronate investigation in asthma, with Phase 2 and Phase 3 completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Milton S. Hershey Medical Center | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-12-14